Bristol-Myers Squibb names Peter J. Arduini to board of directors
Bristol-Myers Squibb Company announced that its Board of Directors has elected Peter J. Arduini to the Board, effective April 1, 2016. Mr. Arduini will serve as a member of the Audit Committee of the Board of Directors, effective May 3, 2016.
Mr. Arduini, 51, is currently president and chie ... more
Phase 2a Study of HIV-1 Investigational Maturation Inhibitor
Bristol-Myers Squibb Company announced overall antiviral activity and safety results from the three-part Phase 2a proof-of-concept study of BMS-955176, a novel investigational therapy designed to prevent the maturation of HIV-1.The study findings support the continued development of BMS-955 ... more
Bristol-Myers Squibb appoints Paul Biondi Senior Vice President, Head of Business Development
Bristol-Myers Squibb Company announced that Paul Biondi has been appointed senior vice president, head of Business Development and will report to Charlie Bancroft, chief financial officer. In this role, Biondi will lead the development of strategic partnerships and pursue scientific innovat ... more